These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19050301)

  • 1. Pediatric giant cell glioblastoma: New insights into a rare tumor entity.
    Karremann M; Butenhoff S; Rausche U; Pietsch T; Wolff JE; Kramm CM
    Neuro Oncol; 2009 Jun; 11(3):323-9. PubMed ID: 19050301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.
    Bin Abdulrahman AK; Bin Abdulrahman KA; Bukhari YR; Faqihi AM; Ruiz JG
    Brain Behav; 2019 Oct; 9(10):e01402. PubMed ID: 31464386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Kozak KR; Moody JS
    Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
    Lam S; Lin Y; Zinn P; Su J; Pan IW
    J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
    Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
    J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
    Jin MC; Wu A; Xiang M; Azad TD; Soltys SG; Li G; Pollom EL
    World Neurosurg; 2019 Aug; 128():e217-e224. PubMed ID: 31009783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiological characteristics of pediatric gliosarcomas.
    Karremann M; Rausche U; Fleischhack G; Nathrath M; Pietsch T; Kramm CM; Wolff JE
    J Neurooncol; 2010 Apr; 97(2):257-65. PubMed ID: 19806321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
    Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
    Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
    Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
    Pan IW; Ferguson SD; Lam S
    J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of pediatric gliomas: implications for the development of future therapies.
    Pytel P
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S51-60. PubMed ID: 18076319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide.
    Topkan E; Topuk S; Oymak E; Parlak C; Pehlivan B
    Am J Clin Oncol; 2012 Jun; 35(3):284-9. PubMed ID: 21399487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
    Kase M; Vardja M; Lipping A; Asser T; Jaal J
    Radiother Oncol; 2011 Oct; 101(1):127-31. PubMed ID: 21775006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.